{"owner": "ArrayExpress Uploader", "pop_total": 0, "id": 3447, "factors": [{"GSM461114": {"TREATMENT": "untreated"}}, {"GSM461114": {"TREATMENT": "untreated"}}, {"GSM461116": {"TREATMENT": "CDK-125"}}, {"GSM461116": {"TREATMENT": "CDK-125"}}], "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "The effects of the CDK inhibitor PHA-848125  (referred to as CDK-125) on the MCF7 human adenocarcinoma mammary cell line were analysed by...", "pubmed_id": 20679242, "geo_gse_id": "E-GEOD-18501", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 1, "sample_count": 4, "tags": ["adenocarcinoma", "cell", "line"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "cdk-inhibitor-pha-848125-gene-expression-profiling", "geo_id_plat": "E-GEOD-18501_A-AFFY-44", "name": "CDK inhibitor PHA-848125 gene expression profiling on MCF7 cell line", "created": "Sep.15, 2014", "summary": "The effects of the CDK inhibitor PHA-848125  (referred to as CDK-125) on the MCF7 human adenocarcinoma mammary cell line were analysed by gene expression profiling. The MCF7 cell line was treated with PHA-848125 for 6 hours at a dose equal to 5 times the IC50. Untreated MCF7 cells were used as a control. Two replicates per treatment.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-18501", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-18501/samples/"}